<TEXT>&#2;<DATELINE>2007</DATELINE><TITLE>Antivirals become a broader enterprise</TITLE><BODY>Small molecules have dominated antivirals for decades, but other approaches are needed and biologics could show the way.&#3;</BODY></TEXT>